On January 3, 2022 ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, reported their participation in upcoming investor conferences and invites investors to participate in one-on-one meetings (Press release, ERYtech Pharma, JAN 3, 2022, View Source [SID1234598106]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
LifeSci Partners – 11thAnnual Corporate Access Event
Wednesday, January 5th – Friday, January 7thRegistration Link
To submit one-on-one meeting requests Click Here
H.C. Wainwright BioConnect Virtual Conference
Monday, January 10th – Thursday, January 13thRegistration Link
A webcast will be available for 90 days on the Webcasts section of the ERYTECH website on January 10th at 7am ET or by using the following link: View Source
If you are interested in arranging a one-on-one meeting, please contact your conference representative.